Letter: switches of 5-aminosalicylates in ulcerative colitis, risk of relapse and ascertainment bias

被引:1
作者
Curtis, H. [1 ]
Jones, S. [2 ]
Treasure, P. [3 ]
机构
[1] Princess Royal Hosp, Farnborough, Hants, England
[2] Synapse Med Resourcing Ltd, London, England
[3] Peter Treasure Stat Serv Ltd, Kings Lynn, Norfolk, England
关键词
D O I
10.1111/apt.12583
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:344 / 345
页数:2
相关论文
共 3 条
[1]   Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Barrett, Karen ;
Hodgson, Ian ;
Streck, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) :1064-1077
[2]   Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis [J].
Feagan, Brian G. ;
MacDonald, John K. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)
[3]   Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse [J].
Robinson, A. ;
Hankins, M. ;
Wiseman, G. ;
Jones, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (05) :531-538